ICH stability chambers with continuous monitoring for long-term, intermediate, and accelerated studies supporting FDA ...

Speciality Medicines Limited, a company engaged in the marketing and distribution of specialty pharmaceutical products ...

Generic drugmakers in India launch affordable Semaglutide versions, targeting a $1 billion diabetes and weight loss market.

Following the patent expiry of semaglutide in India, leading pharma companies including Sun Pharma, Dr Reddy’s, Zydus, and ...

Indian pharma majors Sun Pharma, Dr Reddy’s and Glenmark on Saturday announced the launch of their generic versions of semaglutide injection used for diabetes and weight management following the ...

Built on a pharmaceutical legacy spanning over four decades, SKINLUV has emerged as a dedicated platform for dermatologist-recommended skincare, aiming to simplify how consumers access clinically ...

This biotech firm develops therapies for rare, complement-driven diseases, with a focus on autoimmune and inflammatory conditions.

Nearly 90,000 bottles of children's ibuprofen have been recalled because of the potential presence of a foreign substance.

Generic semaglutide launches by seven drugmakers, priced 50-80% lower than Novo Nordisk’s original products for diabetes and obesity.

Nearly 90,000 bottles of children's ibuprofen are being voluntarily recalled due to the potential presence of a foreign substance. According to a notice from the Food and Drug Administration, Taro ...

Nearly 90,000 bottles of a children’s pain reliever have been recalled due to reports of black specs and other contaminants, ...

Corporations with excellent dividend programs are especially worth a second look right now. In that spirit, let's consider a ...